Please provide your email address to receive an email when new articles are posted on . The eye tracker yielded appropriately different blink measurements depending on user activity. The device could ...

Below is Validea's guru fundamental report for NATIONAL VISION HOLDINGS INC (EYE). Of the 22 guru strategies we follow, EYE rates highest using our Price/Sales Investor model based on the published ...

“This cost-utility analysis confirms what many of us in clinical practice have observed,” said Nathan Lighthizer, OD, FAAO, lead investigator of the study and Professor and Dean for the NSU Oklahoma ...

Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

Two phase 3 trials evaluating a subcutaneous (SC) formulation of efgartigimod (efgartigimod alfa and hyaluronidase-qvfc [PH20]), a neonatal Fc receptor blocker, for the treatment of moderate to severe ...